Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models

• Matteo Centonze,
• Giusy Di Conza,
• Michael Lahn,
• Isabel Fabregat,
• Francesco Dituri,
• Isabella Gigante,
• Grazia Serino,
• Rosanna Scialpi,
• Livianna Carrieri,
• Roberto Negro,
• Elena Pizzuto,
• Gianluigi Giannelli

Affiliations

Matteo Centonze

National Institute of Gastroenterology - IRCCS “Saverio de Bellis”

Giusy Di Conza

iOnctura SA

Michael Lahn

iOnctura SA

Isabel Fabregat

TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) and CIBEREHD ? ISCIII

Francesco Dituri

National Institute of Gastroenterology - IRCCS “Saverio de Bellis”

Isabella Gigante

National Institute of Gastroenterology - IRCCS “Saverio de Bellis”

Grazia Serino

National Institute of Gastroenterology - IRCCS “Saverio de Bellis”

Rosanna Scialpi

National Institute of Gastroenterology - IRCCS “Saverio de Bellis”

Livianna Carrieri

National Institute of Gastroenterology - IRCCS “Saverio de Bellis”

Roberto Negro

National Institute of Gastroenterology - IRCCS “Saverio de Bellis”

Elena Pizzuto

National Institute of Gastroenterology - IRCCS “Saverio de Bellis”

Gianluigi Giannelli

National Institute of Gastroenterology - IRCCS “Saverio de Bellis”